Coral Laboratories Limited (BOM:524506)
India
· Delayed Price · Currency is INR 440.75
+8.20 (1.90%)
At close: Mar 9, 2026
Coral Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 875.55 | 1,150 | 836.6 | 781.19 | 756.11 | 965.67 | Upgrade
|
| Other Revenue | 0 | - | - | - | - | - | Upgrade
|
| Revenue | 875.55 | 1,150 | 836.6 | 781.19 | 756.11 | 965.67 | Upgrade
|
| Revenue Growth (YoY) | -24.36% | 37.47% | 7.09% | 3.32% | -21.70% | 36.82% | Upgrade
|
| Cost of Revenue | 405.86 | 540.65 | 381.04 | 467.73 | 408.04 | 521.98 | Upgrade
|
| Gross Profit | 469.69 | 609.4 | 455.57 | 313.46 | 348.07 | 443.7 | Upgrade
|
| Selling, General & Admin | 157.64 | 151.46 | 121.4 | 112.93 | 117.5 | 125.91 | Upgrade
|
| Other Operating Expenses | 191.43 | 191.88 | 168.3 | 157.99 | 144.69 | 155.13 | Upgrade
|
| Operating Expenses | 370.08 | 363.45 | 309.46 | 292.73 | 282.1 | 300.87 | Upgrade
|
| Operating Income | 99.62 | 245.95 | 146.11 | 20.73 | 65.97 | 142.83 | Upgrade
|
| Interest Expense | -2 | -0.98 | -0 | -3.39 | -1.41 | -0.43 | Upgrade
|
| Interest & Investment Income | 48.39 | 48.39 | 33.56 | 17.87 | 17.49 | 20.45 | Upgrade
|
| Currency Exchange Gain (Loss) | 14.88 | 14.88 | 9.51 | 32.35 | 13.83 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 30.37 | 24.15 | 19.78 | 14.31 | 13.09 | 13.08 | Upgrade
|
| EBT Excluding Unusual Items | 191.26 | 332.4 | 208.96 | 81.88 | 108.96 | 175.94 | Upgrade
|
| Other Unusual Items | -4.47 | -7.7 | -1.64 | 0.38 | 9.59 | 0.19 | Upgrade
|
| Pretax Income | 186.79 | 324.7 | 207.32 | 82.26 | 118.56 | 176.12 | Upgrade
|
| Income Tax Expense | 46.95 | 83.15 | 49.43 | 17.81 | 28.1 | 40.58 | Upgrade
|
| Net Income | 139.84 | 241.56 | 157.89 | 64.45 | 90.46 | 135.55 | Upgrade
|
| Net Income to Common | 139.84 | 241.56 | 157.89 | 64.45 | 90.46 | 135.55 | Upgrade
|
| Net Income Growth | -48.43% | 52.99% | 144.97% | -28.75% | -33.27% | 90.10% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| EPS (Basic) | 39.14 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | Upgrade
|
| EPS (Diluted) | 39.14 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | Upgrade
|
| EPS Growth | -48.42% | 52.99% | 144.97% | -28.75% | -33.27% | 90.10% | Upgrade
|
| Free Cash Flow | - | -41.67 | -64.56 | 107.2 | 5.35 | -4.29 | Upgrade
|
| Free Cash Flow Per Share | - | -11.66 | -18.07 | 30.01 | 1.50 | -1.20 | Upgrade
|
| Dividend Per Share | - | 1.500 | 2.000 | - | - | - | Upgrade
|
| Dividend Growth | - | -25.00% | - | - | - | - | Upgrade
|
| Gross Margin | 53.64% | 52.99% | 54.45% | 40.13% | 46.03% | 45.95% | Upgrade
|
| Operating Margin | 11.38% | 21.39% | 17.46% | 2.65% | 8.72% | 14.79% | Upgrade
|
| Profit Margin | 15.97% | 21.00% | 18.87% | 8.25% | 11.96% | 14.04% | Upgrade
|
| Free Cash Flow Margin | - | -3.62% | -7.72% | 13.72% | 0.71% | -0.45% | Upgrade
|
| EBITDA | 119.78 | 265.92 | 165.82 | 42.45 | 85.75 | 162.48 | Upgrade
|
| EBITDA Margin | 13.68% | 23.12% | 19.82% | 5.43% | 11.34% | 16.83% | Upgrade
|
| D&A For EBITDA | 20.16 | 19.97 | 19.71 | 21.72 | 19.78 | 19.65 | Upgrade
|
| EBIT | 99.62 | 245.95 | 146.11 | 20.73 | 65.97 | 142.83 | Upgrade
|
| EBIT Margin | 11.38% | 21.39% | 17.46% | 2.65% | 8.72% | 14.79% | Upgrade
|
| Effective Tax Rate | 25.13% | 25.61% | 23.84% | 21.65% | 23.70% | 23.04% | Upgrade
|
| Revenue as Reported | 972.86 | 1,241 | 902.93 | 850.14 | 804.24 | 1,003 | Upgrade
|
| Advertising Expenses | - | 4.09 | 9.41 | 1.6 | 5.24 | 24.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.